The Association of Soluble IGF2R and IGF2R Gene Polymorphism with Type 2 Diabetes

被引:21
作者
Chanprasertyothin, Suwannee [1 ]
Jongjaroenprasert, Wallaya [2 ]
Ongphiphadhanakul, Boonsong [2 ]
机构
[1] Mahidol Univ, Ramathibodi Hosp, Res Ctr, Bangkok 10400, Thailand
[2] Mahidol Univ, Ramathibodi Hosp, Dept Med, Bangkok 10400, Thailand
关键词
GROWTH-FACTOR-II; ACAA-INSERTION/DELETION POLYMORPHISM; FACTOR; RECEPTOR; COMMON VARIANTS; INSULIN; CDKAL1; CDKN2A/B; SLC30A8; HHEX; GLUCOSE;
D O I
10.1155/2015/216383
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study is to investigate the insulin-like growth factor type 2 (IGF2R) gene and circulating soluble IGF2R in relation to type 2 diabetes (T2DM). Six hundred fifty-four subjects without history of diabetes were screened for diabetes by oral glucose tolerance test. In addition, 145 subjects with known diabetes were recruited from a local diabetes clinic. Circulating IGF2R levels were measured by ELISA method; plasma glucose was measured by colorimetric method; insulin levels were determined by chemiluminescent method; IGF2R gene rs416572 was genotyped using real-time PCR. The distributions of IGF2R genotypes were 69.2% CC, 27.8% CT, and 3.0% TT. The C allele was more commonly found in diabetes subjects, with a significant difference (P < 0.01). In the presence of the T allele, circulating IGF2R levels were significantly lower (P < 0.05). There was no significant difference in other potential confounders including age, sex, and BMI. Only circulating IGF2R, age, and BMI were independently associated with the degree of insulin resistance, as assessed by the HOMA model. It was found that age, sex, and BMI were associated with beta cell function. In conclusion, IGF2R gene polymorphism and circulating IGF2R are associated with T2DM.
引用
收藏
页数:5
相关论文
共 22 条
[1]  
Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc12-s011]
[2]   Defective IGF2 and IGF1R protein production in embryonic pancreas precedes beta cell mass anomaly in the Goto-Kakizaki rat model of type 2 diabetes [J].
Calderari, S. ;
Gangnerau, M.-N. ;
Thibault, M. ;
Meile, M.-J. ;
Kassis, N. ;
Alvarez, C. ;
Portha, B. ;
Serradas, P. .
DIABETOLOGIA, 2007, 50 (07) :1463-1471
[3]   Impact of Common Variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the Risk of Type 2 Diabetes in 5,164 Indians [J].
Chauhan, Ganesh ;
Spurgeon, Charles J. ;
Tabassum, Rubina ;
Bhaskar, Seema ;
Kulkarni, Smita R. ;
Mahajan, Anubha ;
Chavali, Sreenivas ;
Kumar, M. V. Kranthi ;
Prakash, Swami ;
Dwivedi, Om Prakash ;
Ghosh, Saurabh ;
Yajnik, Chittaranjan S. ;
Tandon, Nikhil ;
Bharadwaj, Dwaipayan ;
Chandak, Giriraj R. .
DIABETES, 2010, 59 (08) :2068-2074
[4]   Genome-wide association studies provide new insights into type 2 diabetes aetiology [J].
Frayling, Timothy M. .
NATURE REVIEWS GENETICS, 2007, 8 (09) :657-662
[5]   Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects -: Validation and extension of genome-wide association studies [J].
Grarup, Niels ;
Rose, Chrisian S. ;
Andersson, Ehm A. ;
Andersen, Gitte ;
Nielsen, Arne L. ;
Albrechtsen, Anders ;
Clausen, Jesper O. ;
Rasmussen, Signe S. ;
Jorgensen, Torben ;
Sandbaek, Annelli ;
Lauritzen, Torsten ;
Schmitz, Ole ;
Hansen, Torben ;
Pedersen, Oluf .
DIABETES, 2007, 56 (12) :3105-3111
[6]   Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps [J].
Groenewoud, M. J. ;
Dekker, J. M. ;
Fritsche, A. ;
Reiling, E. ;
Nijpels, G. ;
Heine, R. J. ;
Maassen, J. A. ;
Machicao, F. ;
Schaefer, S. A. ;
Haering, H. U. ;
't Hart, L. M. ;
van Haeften, T. W. .
DIABETOLOGIA, 2008, 51 (09) :1659-1663
[7]   The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis [J].
Holt, RIG ;
Simpson, HL ;
Sönksen, PH .
DIABETIC MEDICINE, 2003, 20 (01) :3-15
[8]   Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetes [J].
Jeyaratnaganthan, Nilani ;
Hojlund, Kurt ;
Kroustrup, Jens Peter ;
Larsen, Jens Fromholt ;
Bjerre, Mette ;
Levin, Klavs ;
Beck-Nielsen, Henning ;
Frago, Susana ;
Hassan, A. Bassim ;
Flyvbjerg, Allan ;
Frystyk, Jan .
GROWTH HORMONE & IGF RESEARCH, 2010, 20 (03) :185-191
[9]   Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population [J].
Lee, Yong-Ho ;
Kang, Eun Seok ;
Kim, So Hun ;
Han, Seung Jin ;
Kim, Chul Hoon ;
Kim, Hyeong Jin ;
Ahn, Chul Woo ;
Cha, Bong Soo ;
Nam, Moonsuk ;
Nam, Chung Mo ;
Lee, Hyun Chul .
JOURNAL OF HUMAN GENETICS, 2008, 53 (11-12) :991-998
[10]   Soluble M6P/IGF2R Released by TACE Controls Angiogenesis via Blocking Plasminogen Activation [J].
Leksa, Vladimir ;
Loewe, Robert ;
Binder, Brigitte ;
Schiller, Herbert B. ;
Eckerstorfer, Paul ;
Forster, Florian ;
Soler-Cardona, Ana ;
Ondrovicova, Gabriela ;
Kutejova, Eva ;
Steinhuber, Eva ;
Breuss, Johannes ;
Drach, Johannes ;
Petzelbauer, Peter ;
Binder, Bernd R. ;
Stockinger, Hannes .
CIRCULATION RESEARCH, 2011, 108 (06) :676-U323